September 18, 2007 - Baseline data from the largest study of U.S.-based heart failure (HF) patients in the outpatient setting demonstrate significant gaps and variation in medical care, particularly for women and the elderly, according to findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) study.

The study, sponsored by Medtronic Inc., was presented in a poster session at the Heart Failure Society of America Annual Scientific Meeting.

September 18, 2007 - The DuraHeart Left Ventricular Assist System (LVAS) reported a survival rate of 77 percent for all patients at 1 and 2 years, according to Aly El-Banayosy, M.D., from the Heart Center Nordrhein-Westfalen in Bad Oeynhausen, Germany, who presented a summary of the results from the European Clinical Trial at the European Association of Cardio-Thoracic Surgeons (EACTS) meeting in Geneva, Switzerland.

September 18, 2007 – CardioDynamics, an impedance cardiography (ICG) technology developer, announced plans to accelerate the its return to profitability capitalizing on the proceeds from the $8 million sale of Vermed, providing for strategic investments in revenue growth initiatives and expense reductions, including a 10 percent reduction in executive salaries.

September 18, 2007 - Vasogen Inc. announced plans for a confirmatory study of its Celacade technology for the treatment of patients with NYHA Class II heart failure, in order to support an application for regulatory approval in the U.S.

September 18, 2007 - Forty-one U.S. hospitals have been named 2007 Leapfrog Top Hospitals, based on results from the Leapfrog Hospital Quality and Safety Survey, a rating system that provides an up-to-the-minute assessment of a hospital's quality and safety.

September 18, 2007 - St. Jude Medical Inc. announced FDA approval of its first radiofrequency (RF) wireless devices to treat patients with heart failure and with potentially lethal heart arrhythmias.

September 17, 2007 – GHX announced the winners of the fourth annual Best In Class Awards, recognizing medical/surgical and clinical laboratory manufacturers that have achieved top market position in their respective product and market segment categories for distributed products through the end of 2006.

September 14, 2007 - In the largest study of its kind to date, comparing the CYPHER Sirolimus-eluting Coronary Stent and the Taxus Stent to bare-metal stents, researchers found that the mortality risks associated with drug-eluting stents and bare-metal stents are similarly low.

September 14, 2007 - Boston Scientific Corp. released data reflecting experience from the first 15,000 patients monitored wirelessly on the LATITUDE Patient Management System, a device that detects clinical events between scheduled follow-up visits and then sends the clinical event data directly to physicians, enabling clinicians to observe these events sooner.

September 14, 2007 - For many years, American Heart Association research has supported education and training programs for Emergency Cardiovascular Care (ECC) that save thousands of lives each year, and now healthcare providers have easier access to these programs using the eLearning program.

Subscribe Now